SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-20-010850
Filing Date
2020-10-06
Accepted
2020-10-06 07:46:34
Documents
3
Period of Report
2020-10-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT gtbp_8k.htm 8-K 30019
2 MASTER SERVICES AGREEMENT gtbp_ex101.htm EX-10.1 318915
3 PRESS RELEASE gtbp_ex991.htm EX-99.1 17690
  Complete submission text file 0001654954-20-010850.txt   368073
Mailing Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362
Business Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-08092 | Film No.: 201225586
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences